Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula M Jacobs

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Launch of the american journal of nuclear medicine and molecular imagingBelinda Seto, Paula M Jacobs, Abass Alavi, et al.
Medchemcomm|November 29, 2014
Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancersSibaprasad Bhattacharyya, Nimit Patel, Ling Wei, et al.
Radiology|February 28, 2007
Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experienceWei Li, John Salanitri, Sean Tutton, et al.
Nuclear Medicine and Biology|March 5, 2013
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomasSibaprasad Bhattacharyya, Karen Kurdziel, Ling Wei, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 16, 2017
Dosimetry and first human experience with <sup>89</sup>Zr-panitumumabLiza Lindenberg, Stephen Adler, Ismail B Turkbey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid TumorsColin R Young, Stephen Adler, Janet F Eary, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 22, 2005
Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labelingApril D Yancy, Alan R Olzinski, Tom C-C Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities-Phase III StudiesSanjiv S Gambhir, Lalitha K Shankar, Eben Rosenthal, et al.
Neurosurgery|April 7, 2007
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot studyEdward A Neuwelt, Csanád G Várallyay, Sándor Manninger, et al.
Journal of Translational Medicine|August 18, 2022
3'-[<sup>18</sup>F]fluoro-3'-deoxythymidine ([<sup>18</sup>F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumorJames L Tatum, Joseph D Kalen, Paula M Jacobs, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Launch of the american journal of nuclear medicine and molecular imagingBelinda Seto, Paula M Jacobs, Abass Alavi, et al.
Medchemcomm|November 29, 2014
Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancersSibaprasad Bhattacharyya, Nimit Patel, Ling Wei, et al.
Radiology|February 28, 2007
Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experienceWei Li, John Salanitri, Sean Tutton, et al.
Nuclear Medicine and Biology|March 5, 2013
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomasSibaprasad Bhattacharyya, Karen Kurdziel, Ling Wei, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 16, 2017
Dosimetry and first human experience with <sup>89</sup>Zr-panitumumabLiza Lindenberg, Stephen Adler, Ismail B Turkbey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid TumorsColin R Young, Stephen Adler, Janet F Eary, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 22, 2005
Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labelingApril D Yancy, Alan R Olzinski, Tom C-C Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities-Phase III StudiesSanjiv S Gambhir, Lalitha K Shankar, Eben Rosenthal, et al.
Neurosurgery|April 7, 2007
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot studyEdward A Neuwelt, Csanád G Várallyay, Sándor Manninger, et al.
Journal of Translational Medicine|August 18, 2022
3'-[<sup>18</sup>F]fluoro-3'-deoxythymidine ([<sup>18</sup>F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumorJames L Tatum, Joseph D Kalen, Paula M Jacobs, et al.
Pageof 3